标签: North America

北美洲

  • Drug lord El Chapo’s son pleads guilty in US drug trafficking case

    Drug lord El Chapo’s son pleads guilty in US drug trafficking case

    In a significant blow to Mexico’s most powerful drug trafficking organization, Joaquín Guzmán López, 39, has entered a guilty plea to narcotics charges in a United States federal court. The defendant—one of four sons of imprisoned kingpin Joaquín ‘El Chapo’ Guzmán—acknowledged his criminal activities as part of a plea agreement reached with U.S. prosecutors.

    This judicial development follows the U.S. government’s commitment last May to exclude capital punishment from potential sentencing. Guzmán López represents the second consecutive son from the notorious ‘Los Chapitos’ faction to admit guilt this year, following his brother Ovidio’s July confession to drug trafficking, firearms, and money laundering violations.

    Federal prosecutors assert that the Guzmán siblings ascended to leadership roles within the Sinaloa Cartel following their father’s 2019 life sentence conviction and subsequent imprisonment at Colorado’s ADX Florence supermax facility. The criminal organization, co-founded by El Chapo and currently led by Ismael ‘El Mayo’ Zambada, remains one of Mexico’s most prolific drug syndicates.

    Guzmán López’s arrest occurred last year after his private aircraft landed in Texas, where authorities apprehended him alongside cartel boss Zambada. The guilty plea emerges amid heightened political tensions regarding U.S. counter-narcotics strategies, including the Trump administration’s controversial missile strikes against suspected maritime drug traffickers and proposals to designate cartels as terrorist organizations.

    The administration justifies these aggressive measures as necessary interventions to combat the opioid crisis and prevent narcotics-related fatalities within American borders. This case underscores the ongoing international efforts to dismantle transnational criminal networks through judicial cooperation and targeted law enforcement operations.

  • Dubai’s Rayhan Thomas aims to secure 2026 Korn Ferry Tour status in Savannah

    Dubai’s Rayhan Thomas aims to secure 2026 Korn Ferry Tour status in Savannah

    Dubai-born golf professional Rayhan Thomas arrives in Savannah, Georgia this week for a critical career milestone: Stage Two of the Korn Ferry Tour Qualifying School at The Landings Golf & Athletic Club. The 26-year-old athlete, who narrowly missed automatic qualification by finishing 88th in the 2025 season standings, brings both experience and determination to the December 2-5 competition.

    Thomas enters the qualifier with significant momentum from his impressive Stage One performance in Nebraska, where he carded four consecutive sub-70 rounds (67-69-67-66) to finish 15-under-par and secure a tied-fourth position. The Deer Creek course at Savannah holds particular significance for Thomas, having previously competed there during last year’s qualifying stage and official Korn Ferry Tour events.

    “I’m excited about what lies ahead,” Thomas told Khaleej Times. “I’ve always played well around this course, so fingers crossed I can keep that run going. I’m feeling good with my game and strong physically and mentally after a break from Stage One.”

    The Tom Fazio-designed championship layout stretches 7,049 yards as a par-72 challenge that will test 76 competitors under predicted challenging weather conditions. Thomas acknowledged the forecasted cold and windy weather but maintained his competitive perspective: “It’s the same for everyone, and as with all qualifying, I just want to play my best and hopefully get through this week.”

    Successful advancement would see Thomas progress to the Final Qualifying stage at TPC Sawgrass and Sawgrass Country Club in Ponte Vedra Beach, Florida (December 11-14), where the ultimate prizes include PGA Tour cards for the top five finishers and full Korn Ferry Tour membership for the next 40 competitors.

    Representing Dubai Creek Golf & Yacht Club with sponsorship support from Hero, Wilson, Cadillac, and Dubai Basketball, the Indian-descent golfer stands at the threshold of securing his professional future through four days of intense competition.

  • US Navy commander ordered second  Venezuela boat strike, White House says

    US Navy commander ordered second Venezuela boat strike, White House says

    The White House has issued a robust defense of U.S. military operations targeting suspected Venezuelan narcotics vessels in the Caribbean, affirming that a senior Navy commander acted within legal parameters when authorizing lethal strikes. Press Secretary Karoline Leavitt confirmed on Monday that Admiral Frank Bradley operated “well within his authority and the law” in ordering additional military action against an alleged drug-smuggling boat.

    The administration forcefully denied allegations reported by the Washington Post that Defense Secretary Pete Hegseth had issued verbal commands to “kill everybody” aboard targeted vessels. Both Hegseth and White House officials characterized these claims as “fabricated, inflammatory, and derogatory,” with President Trump expressing complete confidence in his defense secretary.

    This military campaign, framed as a counter-narcotics initiative, has resulted in over 80 fatalities since early September. The Trump administration characterizes these operations as acts of self-defense against presidentially designated narco-terrorist groups transporting illicit drugs toward American shores.

    The strikes have triggered bipartisan concern in Congress, with both the Senate and House Armed Services Committees initiating inquiries into the operational circumstances. Senators Roger Wicker and Jack Reed announced vigorous oversight measures to establish factual clarity regarding engagement protocols.

    Internationally, Venezuela’s National Assembly has condemned the military actions and pledged thorough investigation into allegations of secondary strikes that reportedly killed survivors. The Venezuelan government accuses the United States of deliberately escalating regional tensions to undermine its sovereignty.

    The legal framework governing these operations remains contentious, with the administration classifying the campaign as a non-international armed conflict against drug traffickers. This classification invokes Geneva Convention provisions prohibiting targeting of wounded participants and mandating their apprehension and medical care.

    The current controversy echoes previous scrutiny of U.S. engagement protocols during the Obama administration, particularly regarding drone strike practices that sometimes resulted in unintended casualties.

  • ‘Rage bait’ crowned Oxford’s word of the year for 2025

    ‘Rage bait’ crowned Oxford’s word of the year for 2025

    Oxford University Press has declared ‘rage bait’ as its 2025 Word of the Year, selecting the term that encapsulates the modern digital phenomenon of content specifically engineered to provoke anger and outrage for increased online engagement. The selection process incorporated both public voting and sophisticated analysis of lexical data from OUP’s extensive language corpus.

    The winning term surpassed two other notable finalists: ‘aura farming,’ which describes the strategic cultivation of a charismatic personal image, and ‘biohack,’ referring to self-directed biological optimization through lifestyle and technological interventions. According to Oxford’s official definition, ‘rage bait’ constitutes ‘online content deliberately designed to elicit anger or outrage through frustrating, provocative, or offensive material, typically posted to amplify web traffic or user interaction.’

    Casper Grathwohl, President of OUP’s Languages Division, emphasized that these contemporary terms demonstrate how digital platforms are fundamentally transforming human cognition and behavior. ‘These selections represent a natural progression in our ongoing dialogue about humanity’s place within a technology-dominated world and the peculiar extremes of online culture,’ Grathwohl stated in an official release.

    The democratic element of the selection process saw participation from over 30,000 global voters during a three-day voting window. This marks the fourth consecutive year incorporating public input in the final decision, though OUP experts simultaneously tracked actual usage patterns across a massive 30-billion-word database of global language data to validate the choice.

    This year’s selection continues Oxford’s tradition of identifying terms that capture the cultural moment, following previous winners including 2023’s ‘rizz’ (denoting personal charm) and 2024’s ‘brain rot.’ The public voting mechanism began in 2022 when ‘goblin mode’ emerged victorious. Prior to this public involvement phase, Oxford’s lexicographers independently selected such culturally significant terms as ‘vax’ (2021), ‘climate emergency’ (2019), and ‘selfie’ (2013).

  • UAE: Mother wakes from 3-month coma to discover she gave birth to baby girl

    UAE: Mother wakes from 3-month coma to discover she gave birth to baby girl

    A Jordanian expatriate residing in Ajman has emerged from one of the longest documented ECMO (Extracorporeal Membrane Oxygenation) cases in medical history, awakening after three months in a coma to discover she had given birth during her unconsciousness. Amal Othman, 40, survived a harrowing medical ordeal that began with a severe influenza infection during her Umrah pilgrimage while pregnant.

    Her condition rapidly deteriorated into Acute Respiratory Distress Syndrome (ARDS) accompanied by hemothorax and pneumothorax—life-threatening accumulations of blood and air in the chest cavity. Cleveland Clinic Abu Dhabi’s critical care team implemented ECMO support for an unprecedented 324 days, representing one of the most prolonged applications of this advanced life support technology worldwide.

    Medical director Dr. Fadi Hamed described the case as ‘exceptionally complex,’ requiring coordinated surgical interventions and sustained critical care management. ‘This patient’s journey demonstrates the remarkable outcomes possible through fully integrated team medicine and persistent hope,’ Dr. Hamed stated.

    Upon regaining consciousness, Othman experienced complete paralysis and temporary voice loss, unaware of both the duration of her hospitalization and the successful delivery of her daughter months earlier. Her husband gradually revealed the reality of her situation, including the birth of their child—a revelation the mother characterizes as ‘the beginning of hope’ after existing ‘between life and death.’

    Remarkably, Othman reported vivid visions during her comatose state that corresponded with actual events, including her family’s relocation to a new residence. Her recovery involved extensive rehabilitation under physical therapist Rami Boyles, who noted her progression from complete immobility to regained mobility with assisted walking.

    Despite her miraculous recovery, Othman continues to face medical challenges, including the need for future colon transplantation due to treatment-related complications. She has appealed for financial support to complete her ongoing surgical requirements, emphasizing that while her survival represents a medical milestone, her healing journey continues.

  • Mangione in court as lawyers seek to rule out notebook, gun and other key evidence

    Mangione in court as lawyers seek to rule out notebook, gun and other key evidence

    The Manhattan courtroom became the stage for a pivotal legal battle as Luigi Mangione, the 27-year-old defendant charged with the murder of United Healthcare CEO Brian Thompson, appeared for a multi-day pre-trial hearing. The proceedings center on defense motions to suppress crucial evidence, including a firearm and personal writings allegedly outlining a motive.

    Mangione, who pleaded not guilty to both state and federal murder charges that carry potential death penalty implications, attended Monday’s hearing in a grey suit after court personnel removed his restraints. His legal team is challenging the admissibility of evidence obtained during his December 2024 arrest at a Pennsylvania McDonald’s days after the shooting.

    Defense attorneys argue constitutional violations occurred when police conducted warrantless searches of Mangione’s backpack and obtained statements before reading Miranda rights. Prosecutors maintain the 9mm handgun recovered matches the weapon used in the daylight shooting of Thompson, a father of two, as he entered a Manhattan investors’ conference.

    The notebook in question allegedly contains writings describing what prosecutors characterize as anti-health insurance industry sentiments, referring to ‘the deadly, greed fueled health insurance cartel.’ However, the defense contends these materials were illegally obtained.

    Legal experts observing the case suggest the defense faces significant hurdles. ‘The chances of evidence exclusion are virtually non-existent,’ noted New York criminal defense attorney Dmitriy Shakhnevich, citing exceptions to warrant requirements during manhunts for violent suspects.

    The hearing has featured testimony from law enforcement officials, including NYPD Deputy Commissioner of Public Information Sgt. Chris McLaughlin, and included review of surveillance footage from both the crime scene and arrest location. Prosecutors have indicated additional forensic evidence, including DNA or fingerprints from items discarded near the shooting, strengthens their case.

    Separately, Mangione’s attorneys are seeking to prevent federal prosecutors from pursuing capital punishment, arguing public comments from high-ranking officials like Attorney General Pam Bondi have prejudiced the case through political motivation.

  • Starbucks to pay NYC workers $35m after alleged labour law violations

    Starbucks to pay NYC workers $35m after alleged labour law violations

    Starbucks has reached a historic $35 million settlement with New York City authorities following allegations of systematic violations of the city’s Fair Workweek Law. The agreement, announced Monday, resolves claims that the coffee giant denied predictable schedules and arbitrarily reduced hours for thousands of employees across its NYC locations.

    More than 15,000 hourly workers will receive compensation of $50 for each week worked between July 2021 and July 2024, according to city officials. The settlement represents the largest worker protection agreement in New York City’s history, with investigators documenting over half a million violations of scheduling regulations.

    New York City Department of Consumer and Worker Protection Commissioner Vilda Vera Mayuga stated the investigation revealed ‘a pattern of systemic violations’ across all Starbucks locations in the city. ‘All workers deserve to be treated with dignity,’ Mayuga emphasized, ‘and we are proud to stand up for our neighbors when a multibillion-dollar company chooses to systematically violate their employees’ rights.’

    As part of the settlement, Starbucks must now comply with NYC’s worker protection laws requiring fast-food employers to provide regular schedules and opportunities for additional shifts. The company acknowledged the complexity of the city’s regulations while maintaining its commitment to compliance.

    In a statement, Starbucks noted the compensation represents ‘legal compliance, not unpaid wages’ and reiterated its commitment to ‘creating the best job in retail.’ The company recently announced plans to invest $500 million in coffeehouse staffing and training improvements nationwide.

    The settlement occurs amid ongoing labor tensions between Starbucks and unionized workers. Starbucks Workers United continues to organize strikes across more than 120 stores in 85 cities, demanding better pay, improved staffing levels, and formal union contracts. The union has won representation elections at approximately 5% of company-owned U.S. locations since its formation four years ago.

    New York City Mayor Eric Adams characterized the agreement as a ‘landmark settlement’ that will ‘put tens of millions of dollars back into the pockets of hard-working New Yorkers and reinforce every New Yorker’s right to a reliable schedule, full hours, and basic dignity.’

    The resolution comes as Starbucks navigates multiple challenges including consumer boycotts, increased competition, pricing criticism, and leadership transitions. While the company reported its first quarterly sales growth in nearly two years this October, U.S. sales remained flat, indicating ongoing operational challenges.

  • Appeals court disqualifies ex-Trump lawyer Alina Habba as New Jersey prosecutor

    Appeals court disqualifies ex-Trump lawyer Alina Habba as New Jersey prosecutor

    A significant judicial decision has upended the leadership of New Jersey’s federal prosecutor’s office. The U.S. Court of Appeals for the Third Circuit ruled on Monday that Alina Habba, personally selected by former President Donald Trump for the role, has been serving unlawfully as the U.S. Attorney for New Jersey. This verdict casts doubt on the legitimacy of numerous criminal proceedings she has overseen.

    The controversy stems from the administration’s circumvention of the standard nomination process. After a district court initially rejected Habba’s formal nomination earlier this year, the Trump administration appointed her using a procedural mechanism that allowed her to serve in an ‘acting’ capacity, thereby avoiding the requisite Senate confirmation. The appellate court determined this maneuver to be a direct violation of the Federal Vacancies Reform Act, legislation designed to check executive overreach in appointments.

    This case represents the second instance in recent weeks where a Trump-appointed prosecutor has been disqualified on similar grounds. The ruling emerged from a legal challenge filed by three defendants facing criminal charges in New Jersey, who contested the legality of Habba’s authority to prosecute them. Writing for the court, Judge Michael Fisher noted, ‘It is apparent that the current administration has been frustrated by some of the legal and political barriers to getting its appointees in place.’

    The Department of Justice must now swiftly appoint a lawfully confirmed prosecutor to assume supervision of all federal criminal cases in the district. This development follows a related ruling last week in Virginia, where cases against former FBI Director James Comey and New York Attorney General Letitia James were dismissed because the interim prosecutor, Lindsey Halligan, was also deemed unlawfully appointed.

  • Trump releases fraudster executive days into prison sentence

    Trump releases fraudster executive days into prison sentence

    In a significant executive action, former U.S. President Donald Trump has commuted the prison sentence of David Gentile, the former CEO and founder of GPB Capital Holdings, who had recently begun serving a seven-year term for financial fraud. Federal prison records confirm Gentile’s release on Wednesday, merely days after his incarceration commenced.

    The case stems from a landmark 2023 conviction where federal prosecutors demonstrated that Gentile orchestrated a sophisticated multi-year scheme that defrauded over 10,000 investors. The operation involved systematically misrepresenting the performance of private equity funds, ultimately accumulating approximately $1.6 billion in investor capital. Prosecutors revealed that the firm utilized new investor funds to pay returns to existing investors, a characteristic they labeled as a Ponzi-style operation.

    This clemency decision continues a pattern of Trump intervening in high-profile white-collar criminal cases. Unlike a full presidential pardon, the commutation solely relieves Gentile from serving his prison sentence but does not expunge his criminal record or nullify other potential financial penalties and restitution requirements.

    The White House issued a statement defending the action, alleging prosecutorial misconduct during the Biden administration’s Department of Justice handling of the case. Officials claimed investors were explicitly informed their capital might be allocated to cover other investors’ dividends, fundamentally undermining the prosecution’s characterization of the operation as fraudulent. The statement further cited concerns about allegedly falsified testimony obtained by prosecutors.

    Notably, Gentile’s co-defendant, Jeffry Schneider, who received a six-year sentence on identical charges, remains incarcerated. The contrasting outcomes highlight the extraordinary nature of presidential clemency power in the American justice system.

  • US and UK set to agree zero tariffs deal on pharmaceuticals

    US and UK set to agree zero tariffs deal on pharmaceuticals

    The United Kingdom and United States are poised to announce a landmark trade agreement eliminating proposed pharmaceutical tariffs, following months of tense negotiations and investment diversions by major drug manufacturers. Industry sources indicate the deal could be finalized imminently, potentially as early as today.

    This breakthrough comes after several pharmaceutical giants scaled back UK operations or redirected investments stateside in response to threatened tariff increases of up to 100% on branded medications. The UK’s Department for Business and Trade reports £11.1 billion in medicine exports to the US during the twelve months ending September, representing 17.4% of all UK goods exports during that period.

    Under the anticipated agreement, UK medicine exports will receive three-year protection from tariff escalations while Britain commits to raising its price threshold for expensive new treatments by 25%. Additionally, the National Health Service will increase overall pharmaceutical expenditures, addressing industry concerns about stagnant spending.

    The tariff dispute intensified amid longstanding tensions between pharmaceutical companies and the UK government regarding drug pricing and approval rates. Former Trump administration officials highlighted that American consumers pay significantly more for medications than their UK and European counterparts.

    Recent investment patterns underscore the agreement’s urgency: GSK pledged $30 billion toward US research and manufacturing over five years, while Merck abandoned a planned £1 billion expansion in UK operations. AstraZeneca similarly paused a £200 million Cambridge research facility investment while committing $50 billion to US manufacturing and R&D.

    The agreement represents a delicate balancing act between Health Secretary Wes Streeting’s commitment to preventing drug companies from ‘ripping off’ the UK and Science Minister Sir Patrick Vallance’s acknowledgment that NHS medicine spending must increase after a decade of budgetary decline.